Tonix Pharmaceuticals Holding Corp.
TNXP
$18.62
$0.563.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -17.74% | -5.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.74% | -5.93% | |||
| Cost of Revenue | 246.98% | -20.29% | |||
| Gross Profit | -185.73% | 6.22% | |||
| SG&A Expenses | 60.35% | -35.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 63.90% | -26.25% | |||
| Operating Income | -76.26% | 28.59% | |||
| Income Before Tax | -68.00% | 23.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -68.00% | 23.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -68.00% | 23.88% | |||
| EBIT | -76.26% | 28.59% | |||
| EBITDA | -78.74% | 27.65% | |||
| EPS Basic | -35.90% | 70.93% | |||
| Normalized Basic EPS | -55.18% | 74.54% | |||
| EPS Diluted | -35.90% | 70.93% | |||
| Normalized Diluted EPS | -55.18% | 74.54% | |||
| Average Basic Shares Outstanding | 23.62% | 161.86% | |||
| Average Diluted Shares Outstanding | 23.62% | 161.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||